This marks the latest recall-related issue for HeartMate in recent years. Last June, the FDA deemed another recall as serious ...

Abbott’s mechanical circulatory support device, HeartMate 3 LVAD, is tailored for individuals with advanced heart failure. The device is used for both short- and long-term support in these patients.

Abbott is the maker of the HeartMate 3™ LVAD, which is the only LVAD currently approved in the U.S. Having Abbott assist with many different facets of the Phase 3 TECH-LVAD trial is going to be ...

Abbott’s HeartMate 3™ LVAD is a mechanical circulatory support device designed for patients with advanced heart failure. Abbott’s heart pumps have set the standard in LVAD therapy.

Abbott is the maker of the HeartMate 3™ LVAD, which is the only LVAD currently approved in the U.S. In February 2025, Cadrenal conducted a Type D meeting with the U.S. FDA at which time the ...

were randomly assigned in a 2:1 ratio to undergo implantation of a continuous-flow LVAD (HeartMate II ®) or a pulsatile-flow LVAD (HeartMate XVE ®). The mean age of enrolled patients was 62.5 ...